Leading technology and decades of regulatory expertise, applied to your entire duty‑drawback program. The best matches found, the documents handled, and every drawback filing managed and compliantly supported with Customs.
Software surfaces the opportunity. Licensed specialists own the outcome. You carry none of the burden.
Apollo evaluates every entry and computes the mathematically optimal set of import‑to‑export matches, capturing recovery other providers leave behind.
Records are pulled directly from your brokers, forwarders, and systems, then validated. No email chasing, no manual filing.
A licensed U.S. Customs broker runs the whole program end‑to‑end. Filing accuracy, compliance, audits, and retention, all accountable to CBP.
Drawback is a matching problem: each export must pair to the right import by provision to unlock the most duty. Apollo weighs the entire universe of your entries and pairs them optimally, maximizing what you recover while keeping every claim compliant.
Drawback lives or dies on accurate documentation. Apollo connects to your customs brokers and freight forwarders and collects and validates every record a claim needs. 7501s, invoices, packing lists, bills of lading and more, audit-ready from day one.
Software surfaces the opportunity; our licensed drawback specialists own the execution from start to finish. Assessment, filing, compliance, audits, strategy, and retention. You get the upside of modern technology and the confidence of a 25+ year team that has done this at scale. That includes recovering Section 301 and other tariff duties alongside standard drawback.
A quick introduction to who we are and how we recover duty for your business, end to end. Licensed U.S. Customs brokers with decades of drawback experience.
Tariff rulings and CBP guidance, explained by licensed drawback specialists.
The new Section 301 forced-labor tariffs (10–12.5% on 60 economies, effective July 24, 2026) are recoverable through duty drawback. Here's what that means for your refunds.
When the President’s April 2, 2026 proclamation under Section 232 of the Trade Expansion Act of 1962 (19 U.S.C. § 1862) imposed a default 100% ad valorem duty on imports of patented pharmaceuticals and
Reciprocal tariffs from the Trump administration are now confirmed duty drawback eligible, creating a major opportunity to recover tariffs on imports tied to exports.
See exactly what your business could recover. Our free assessment is the fastest way to find what you're leaving on the table.
Let's talk
